Healthnice Pharmaceutical Overview
- Year Founded
-
2001
- Status
-
IPO Registration
- Employees
-
750
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
14
Healthnice Pharmaceutical General Information
Description
Developer of generic drug development technologies designed for the pharmaceutical industry. The company's drugs are used to treat a range of generic diseases, providing clients with solutions for infrastructure costs, additional expertise and demand production.
Contact Information
Website
www.healthnice.netCorporate Office
- Floor 15, Block A, Science and Technology Innovation Building
- Number 5 Xinmofan Road, Gulou District
- Nanjing, Jiangsu 210031
- China
Corporate Office
- Floor 15, Block A, Science and Technology Innovation Building
- Number 5 Xinmofan Road, Gulou District
- Nanjing, Jiangsu 210031
- China
Healthnice Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. IPO | 07-Nov-2025 | Announced | Profitable | |||
| 9. Merger/Acquisition | 30-Jun-2025 | Cancelled | Profitable | |||
| 8. IPO | 24-Jun-2024 | Cancelled | Profitable | |||
| 7. Secondary Transaction - Private | 01-Sep-2022 | Completed | Profitable | |||
| 6. Early Stage VC (Series B) | 08-Aug-2022 | Completed | Profitable | |||
| 5. Secondary Transaction - Private | 01-Jul-2022 | Completed | Profitable | |||
| 4. Secondary Transaction - Private | 01-Mar-2021 | Completed | Profitable | |||
| 3. Later Stage VC | 28-Dec-2020 | Completed | Profitable | |||
| 2. Later Stage VC | 01-Nov-2018 | Completed | Profitable | |||
| 1. Later Stage VC | 20-Oct-2014 | Completed | Generating Revenue |
Healthnice Pharmaceutical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Healthnice Pharmaceutical Patents
Healthnice Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025251701-A1 | Lyophilized composition containing tolvaptan sodium phosphate and preparation method for lyophilized composition | Pending | 07-Jun-2024 |
Healthnice Pharmaceutical Signals
Healthnice Pharmaceutical Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shandong New Growth Drivers Fund Management | Government | Minority | ||
| Hainan Zhuodai Private Equity Fund Management | Venture Capital | Minority | ||
| Jiangxi State-owned Capital Operation Holding Group | Government | Minority | ||
| Sunland Fund | Venture Capital | Minority | ||
| CICC Capital | PE/Buyout | Minority |
Healthnice Pharmaceutical FAQs
-
When was Healthnice Pharmaceutical founded?
Healthnice Pharmaceutical was founded in 2001.
-
Where is Healthnice Pharmaceutical headquartered?
Healthnice Pharmaceutical is headquartered in Nanjing, China.
-
What is the size of Healthnice Pharmaceutical?
Healthnice Pharmaceutical has 750 total employees.
-
What industry is Healthnice Pharmaceutical in?
Healthnice Pharmaceutical’s primary industry is Drug Discovery.
-
Is Healthnice Pharmaceutical a private or public company?
Healthnice Pharmaceutical is a Private company.
-
What is Healthnice Pharmaceutical’s current revenue?
The current revenue for Healthnice Pharmaceutical is .
-
How much funding has Healthnice Pharmaceutical raised over time?
Healthnice Pharmaceutical has raised $24M.
-
Who are Healthnice Pharmaceutical’s investors?
Shandong New Growth Drivers Fund Management, Hainan Zhuodai Private Equity Fund Management, Jiangxi State-owned Capital Operation Holding Group, Sunland Fund, and CICC Capital are 5 of 14 investors who have invested in Healthnice Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process